Cargando…

Comparison of the benefits of celecoxib combined with anticancer therapy in advanced non-small cell lung cancer: A meta-analysis

Background: Studies have reported that advanced NSCLC benefits from celecoxib combined with systematic treatment. However, the optimal combination with different treatments remains unclear. A meta-analysis was conducted to explore treatment combinations. Methods: We searched the relevant literature...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Yi, Lilan, Shen, Jie, Zhang, Hongman, Luo, Peng, Zhang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052875/ https://www.ncbi.nlm.nih.gov/pubmed/32194793 http://dx.doi.org/10.7150/jca.35003

Ejemplares similares

Systematic review and meta-analysis of the benefit of celecoxib in treating advanced non-small-cell lung cancer
por: Yi, Lilan, et al.
Publicado: (2018)

Efficacy and Safety of Ipilimumab plus Chemotherapy for Advanced Lung Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Hongman, et al.
Publicado: (2018)

Structural Modification of Nanomicelles through Phosphatidylcholine: The Enhanced Drug-Loading Capacity and Anticancer Activity of Celecoxib-Casein Nanoparticles for the Intravenous Delivery of Celecoxib
por: Xv, Liuli, et al.
Publicado: (2020)

Efficacy of erlotinib and celecoxib for patients with advanced non-small cell lung cancer: A retrospective study
por: Jin, Yi-Hua, et al.
Publicado: (2019)

Curcumol potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer
por: Cai, Fangfang, et al.
Publicado: (2017)

Novel combination of celecoxib and metformin improves the antitumor effect by inhibiting the growth of Hepatocellular Carcinoma
por: Hu, Jun-Wen, et al.
Publicado: (2020)

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
por: Khan, O A, et al.
Publicado: (2011)

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
por: Khan, O A, et al.
Publicado: (2011)

TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
por: Lin, Anqi, et al.
Publicado: (2021)

Efficacy and safety of osimertinib in treating EGFR‐mutated advanced NSCLC: A meta‐analysis
por: Yi, Lilan, et al.
Publicado: (2019)

Metformin Synergistically Enhanced the Antitumor Activity of Celecoxib in Human Non-Small Cell Lung Cancer Cells
por: Cao, Nini, et al.
Publicado: (2020)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
por: Qadir, Abdul, et al.
Publicado: (2023)

Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice
por: Zhang, Bo, et al.
Publicado: (2017)

Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy
por: Qiu, Chong, et al.
Publicado: (2023)

Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells
por: Huang, Jianfeng, et al.
Publicado: (2018)

Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial
por: Hayslip, John, et al.
Publicado: (2007)

Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes
por: Yang, Qi, et al.
Publicado: (2021)

Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted mice
por: MENG, XIANYING, et al.
Publicado: (2014)

Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway
por: Liu, Bing, et al.
Publicado: (2017)

Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020)

Combination of fasudil and celecoxib promotes the recovery of injured spinal cord in rats better than celecoxib or fasudil alone
por: Hou, Xiao-lin, et al.
Publicado: (2015)

Cholestatic Hepatitis with Small Duct Injury Associated with Celecoxib
por: Nayudu, Suresh Kumar, et al.
Publicado: (2013)

A comparison of the efficacy of antiangiogenic agents combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis
por: Li, Yimin, et al.
Publicado: (2020)

Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee
por: Zeng, Chao, et al.
Publicado: (2015)

Inhibitory effects and mechanism of 5-fluorouracil combined with celecoxib on human gastric cancer xenografts in nude mice
por: ZHANG, XIAO-QIAN, et al.
Publicado: (2015)

Pooled analysis of the clinical benefit of cyclooxygenase-2 inhibitors combined with chemotherapy in advanced non-small cell lung cancer
por: Zheng, Wei, et al.
Publicado: (2019)

Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer
por: LIU, CHEN-HUI, et al.
Publicado: (2013)

Meta-analysis Comparing Celecoxib with Diclofenac Sodium in Patients with Knee Osteoarthritis
por: Huang, Hetao, et al.
Publicado: (2020)

Risks and benefits of anticancer drugs in advanced cancer patients: A systematic review and meta-analysis
por: Moreau Bachelard, Camille, et al.
Publicado: (2021)

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2011)

Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis
por: Cheng, Bai-Ru, et al.
Publicado: (2021)

Evaluating cost benefits of combination therapies for advanced melanoma
por: Jensen, Ivar S., et al.
Publicado: (2016)

Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data
por: Qi, Wei-Xiang, et al.
Publicado: (2013)

Synthesis and Characterization of Celecoxib Derivatives as Possible Anti-Inflammatory, Analgesic, Antioxidant, Anticancer and Anti-HCV Agents †
por: Küçükgüzel, Ş. Güniz, et al.
Publicado: (2013)

Distinct circulating cytokine/chemokine profiles correlate with clinical benefit of immune checkpoint inhibitor monotherapy and combination therapy in advanced non‐small cell lung cancer
por: Hu, Yue, et al.
Publicado: (2023)

Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
por: Romanò, Carlo Luca, et al.
Publicado: (2009)

Combined effect of sonophoresis and a microemulsion on the dermal delivery of celecoxib
por: Subongkot, Thirapit
Publicado: (2020)

The effect of platelet rich plasma combined with celecoxib on knee function and pain in patients with knee osteoarthritis
por: Nie, Mingjun, et al.
Publicado: (2022)

Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo
por: He, Jiayang, et al.
Publicado: (2018)

Effectiveness of combined pregabalin and celecoxib for treatment of acute postoperative pain: A meta-analysis and systematic review
por: Ni, Jing-Mei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bbhg624bep3ihn6f52p0o8v3de